GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EvokAI Creative Labs Inc (TSXV:OKAI) » Definitions » Valuation Rank

EvokAI Creative Labs (TSXV:OKAI) Valuation Rank


View and export this data going back to 2023. Start your Free Trial

What is EvokAI Creative Labs Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


EvokAI Creative Labs Valuation Rank Related Terms

Thank you for viewing the detailed overview of EvokAI Creative Labs's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


EvokAI Creative Labs Business Description

Traded in Other Exchanges
N/A
Address
609 Granville Street, Suite 1600, PO Box 10068, Pacific Centre, Vancouver, BC, CAN, V7Y 1C3
EvokAI Creative Labs Inc is a medtech artificial-intelligence-powered company. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. EvokAI tailors its AI algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, and contract research organizations to medical professionals, patients, and healthy individuals aiming at preventing and early detecting any kind of disease and beyond, protecting the aging genome.